These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7510416)

  • 1. Human complement activation by polygeline and dextran 70.
    Videm V; Mollnes TE
    Scand J Immunol; 1994 Mar; 39(3):314-20. PubMed ID: 7510416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of complement activation during bypass by prime manipulation.
    Bonser RS; Dave JR; Davies ET; John L; Taylor P; Gaya H; Lennox SC; Vergani D
    Ann Thorac Surg; 1990 Feb; 49(2):279-83. PubMed ID: 2306150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation during and after open-heart surgery is only marginally affected by the choice of fluid for volume replacement.
    Svennevig JL; Tølløfsrud S; Kongsgaard U; Noddeland H; Mohr B; Ozer M; Mollnes TE
    Perfusion; 1996 Jul; 11(4):326-32. PubMed ID: 8884861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation by polystarch and gelatine volume expanders.
    Watkins J; Wild G; Appleyard TN; Hardy G
    Lancet; 1990 Jan; 335(8683):233. PubMed ID: 1967706
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran 40 (Rheomacrodex) or Polygeline (Haemaccel) as an epidural patch for post dural puncture headache: a neurotoxicity study in a rat model of Dextran 40 and Polygeline injected intrathecally.
    Chanimov M; Berman S; Cohen ML; Friedland M; Weissgarten J; Averbukh Z; Herbert M; Sandbank J; Haitov Z; Bahar M
    Eur J Anaesthesiol; 2006 Sep; 23(9):776-80. PubMed ID: 16836769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70.
    Mellbye OJ; Frøland SS; Lilleaasen P; Svennevig JL; Mollnes TE
    Eur Surg Res; 1988; 20(2):101-9. PubMed ID: 2455645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery.
    Kongsgaard UE; Smith-Erichsen N; Geiran O; Amundsen E; Mollnes TE; Garred P
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):343-7. PubMed ID: 2800971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin.
    Tølløfsrud S; Svennevig JL; Breivik H; Kongsgaard U; Ozer M; Hysing E; Mohr B; Seem E; Geiran O; Abdelnour M
    Acta Anaesthesiol Scand; 1995 Jul; 39(5):671-7. PubMed ID: 7572019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system.
    Roeise O; Garred P; Mollnes TE; Aasen AO
    Eur Surg Res; 1989; 21(1):34-41. PubMed ID: 2714308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
    Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
    Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model.
    Gong J; Larsson R; Ekdahl KN; Mollnes TE; Nilsson U; Nilsson B
    J Clin Immunol; 1996 Jul; 16(4):222-9. PubMed ID: 8840224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the efficacy of dextran, gelatin and human albumin solutions as plasma substitutes].
    Savić J; Pantelić D; Vujnov S; Zunić O
    Vojnosanit Pregl; 1977; 34(3):197-203. PubMed ID: 883144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.